CELL-TARGETING NANOPARTICLES COMPRISING POLYNUCLEOTIDE AGENTS AND USES THEREOF
    2.
    发明申请
    CELL-TARGETING NANOPARTICLES COMPRISING POLYNUCLEOTIDE AGENTS AND USES THEREOF 有权
    包含多核苷酸代谢物的细胞靶向纳米颗粒及其用途

    公开(公告)号:US20120129916A1

    公开(公告)日:2012-05-24

    申请号:US13388161

    申请日:2010-07-29

    申请人: Dan Peer

    发明人: Dan Peer

    摘要: A method of generating a particle is disclosed, the particle being for delivery of a polynucleotide to a target cell. The method comprises (a) contacting the polynucleotide with a composition comprising cationic molecules, wherein the cationic molecules condense the polynucleotide by electrostatic interactions to generate a complex, wherein the cationic molecules are not comprised in a liposome; and (b) covalently binding the complex to a targeting moiety at a pH equal to or below about 4.5, thereby generating the particle for delivery of the polynucleotide agent to the target cell. Use of the particles and compositions comprising same are also disclosed.

    摘要翻译: 公开了产生颗粒的方法,所述颗粒用于将多核苷酸递送至靶细胞。 该方法包括:(a)使多核苷酸与包含阳离子分子的组合物接触,其中阳离子分子通过静电相互作用浓缩多核苷酸以产生复合物,其中阳离子分子不包含在脂质体中; 和(b)在等于或低于约4.5的pH下将复合体与靶向部分共价结合,由此产生用于将多核苷酸试剂递送至靶细胞的颗粒。 还公开了包含它们的颗粒和组合物的用途。

    TREATMENT OR PREVENTION OF INFLAMMATION BY TARGETING CYCLIN D1
    4.
    发明申请
    TREATMENT OR PREVENTION OF INFLAMMATION BY TARGETING CYCLIN D1 审中-公开
    通过定期循环D1治疗或预防炎症

    公开(公告)号:US20100285002A1

    公开(公告)日:2010-11-11

    申请号:US12811229

    申请日:2008-12-30

    CPC分类号: C12N15/113 C12N2310/14

    摘要: In one aspect, the invention relates to the treatment and/or prevention of inflammation by inhibition of cyclin D1. In one embodiment, Th1-mediated inflammation is selectively inhibited or reduced by a method comprising administering an agent that inhibits cyclin D1. In another embodiment, an autoimmune disease or a disorder characterized by or involving a Th1 inflammatory response is treated or prevented in a subject by a method comprising administering to the subject an agent that inhibits cyclin D1.

    摘要翻译: 一方面,本发明涉及通过抑制细胞周期蛋白D1治疗和/或预防炎症。 在一个实施方案中,通过包括施用抑制细胞周期蛋白D1的试剂的方法选择性地抑制或减少Th1介导的炎症。 在另一个实施方案中,通过包括向受试者施用抑制细胞周期蛋白D1的药物的方法,在受试者中治疗或预防特征为或涉及Th1炎症反应的自身免疫疾病或病症。

    Cell-targeting nanoparticles comprising polynucleotide agents and uses thereof
    10.
    发明授权
    Cell-targeting nanoparticles comprising polynucleotide agents and uses thereof 有权
    包含多核苷酸试剂的细胞靶向纳米颗粒及其用途

    公开(公告)号:US09574210B2

    公开(公告)日:2017-02-21

    申请号:US13388161

    申请日:2010-07-29

    申请人: Dan Peer

    发明人: Dan Peer

    摘要: A method of generating a particle is disclosed, the particle being for delivery of a polynucleotide to a target cell. The method comprises (a) contacting the polynucleotide with a composition comprising cationic molecules, wherein the cationic molecules condense the polynucleotide by electrostatic interactions to generate a complex, wherein the cationic molecules are not comprised in a liposome; and (b) covalently binding the complex to a targeting moiety at a pH equal to or below about 4.5, thereby generating the particle for delivery of the polynucleotide agent to the target cell. Use of the particles and compositions comprising same are also disclosed.

    摘要翻译: 公开了产生颗粒的方法,所述颗粒用于将多核苷酸递送至靶细胞。 该方法包括:(a)使多核苷酸与包含阳离子分子的组合物接触,其中阳离子分子通过静电相互作用浓缩多核苷酸以产生复合物,其中阳离子分子不包含在脂质体中; 和(b)在等于或低于约4.5的pH下将复合体与靶向部分共价结合,由此产生用于将多核苷酸试剂递送至靶细胞的颗粒。 还公开了包含它们的颗粒和组合物的用途。